Pharmaceutical Industry Is Manufacturing Growth

The Journal (Newcastle, England), June 28, 2011 | Go to article overview

Pharmaceutical Industry Is Manufacturing Growth


THE North East of England has much to be proud about regarding the pharmaceutical industry located in the region, few places in the world can say that they have the full range of pharmaceutical value chain based there, yet we can.

The region is also the only net exporting region in the UK economy and this is largely down to the industries based on or around chemistry. Up to pounds 3bn of the annual pounds 12bn of exports come from the region's pharmaceutical Industry. More than 35% of the UK's GDP in pharmaceuticals continues to be manufactured here.

There are several of the world's leading pharmaceutical companies based in the region as well as home-grown companies such as Specials Labs, which operates from a base in Prudhoe, while the success of Cramlington-based Aesica Pharmaceuticals has been outstanding by any yardstick.

Following its most successful year to date in 2010, Aesica Pharmaceuticals has doubled in size and has successfully expanded into new markets. The company's vision is to become the world's leading supplier of Active Pharmaceutical Ingredients (APIs) and Formulated Products, and recent developments we hope will enable Aesica to rapidly achieve this.

It is already one of the fastest-growing UK companies, increasing its turnover by 300% in the last five years. In doing so it was ranked 3rd in Deloitte's 2011 Buyout Track 100 as published in The Sunday Times.

In 2010 it acquired Nottingham-based R5 Pharmaceuticals and three European sites from leading Belgian pharmaceutical firm, UCB. In addition, new business development managers were recruited for San Diego and New York in preparation for further expansion across America.

The company now has 1,300 staff compared to the 150 or so that started off the company when it was spun out of BASF.

There has been growth and development at GlaxoSmithKline, MSD, sanofi-aventis, Piramel Healthcare and Shasun Pharma Solutions. Many have reported increased productivity and investment in their manufacturing facilities, particularly into biopharmaceutical capabilities. In some cases, products have been relocating from elsewhere in the world back to the NE factories.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Pharmaceutical Industry Is Manufacturing Growth
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.